Chemical inhibitors of PTPλ include a range of compounds that can bind to and obstruct the enzymatic activity of this protein. Bis(maltolato)oxovanadium(IV) targets PTPλ by occupying the phosphate recognition site, which is crucial for the enzyme's function in removing phosphate groups from its substrates. Similarly, Sodium orthovanadate acts as a competitive inhibitor by mimicking the substrate and vying for the active site of PTPλ, thus inhibiting its phosphatase activity. Zinc chloride, another inhibitor, can either block substrate access to the active site or trigger conformational changes in PTPλ that reduce its catalytic efficiency. Suramin, which is known for its ability to bind to various proteins, also binds to the active site of PTPλ, preventing the enzyme from interacting with its substrates.
Moreover, Phenylarsine oxide operates by interacting with the vicinal dithiols within the active site of PTPλ, a critical component for the enzyme's catalytic action. Sodium stibogluconate inhibits PTPλ by occupying the same site and interfering with substrate dephosphorylation. 3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran-6-sulfonic acid simulates the transition state of the enzyme's phosphate ester substrates, thus acting as a competitive inhibitor. The irreversible inhibitor 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride forms a strong covalent bond with a serine residue in the active site of PTPλ, resulting in sustained inhibition. 5-Iodo-salicylic acid and 4-Hydroxy-3-nitrophenylacetic acid are both competitive inhibitors that mimic the structure of the natural substrates of PTPλ, effectively reducing the enzyme's activity. 2-Sodium-4-amino-5-hydroxy-6-(hydroxymethyl)-3-(2H)-pyridazinone chelates the catalytic metal ion, which is indispensable for PTPλ's activity. Lastly, Oxythiamine disrupts the phosphorylation state of PTPλ by antagonizing thiamine, which is necessary for the enzyme's usual function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
As a reversible phosphatase inhibitor, sodium orthovanadate acts on PTPλ by competing with the substrate for binding at the active site, inhibiting its activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can inhibit PTPλ activity by binding to the active site and preventing substrate access, or by inducing conformational changes that reduce enzymatic activity. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin inhibits PTPλ activity by binding to the enzyme's active site, which blocks substrate access and thus inhibits its phosphatase function. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
This compound inhibits PTPλ by binding to vicinal dithiols in the active site, which is necessary for the catalytic activity of the enzyme. | ||||||
Sodium stibogluconate | 16037-91-5 | sc-202815 | 1 g | $188.00 | 6 | |
Inhibits PTPλ by binding to the phosphate recognition site, interfering with the enzyme's ability to dephosphorylate its substrates. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
This irreversible inhibitor forms a covalent bond with a serine residue in the active site of PTPλ, leading to inhibition of enzymatic activity. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Inhibits PTPλ by binding to the active site and acting as a competitive inhibitor with respect to the enzyme's phosphate substrate. | ||||||